Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Emdeki Utama Tbk. (MDKI) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Emdeki Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Emdeki Utama Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.3K 24h volume), while Emdeki Utama Tbk. trades at Rp189 (market cap 475.67B, 1.2K 24h volume). The key difference: Emdeki Utama Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (7.3K versus 1.2K). Which is the better fit depends on your goals.

DGNSMDKI
Market Cap
319B475.67B
Volume
7.3K1.2K
Lot
7312
Turnover
1.67M229.5K
Average Price
229.21191.25
Value
1.67M229.5K
Indicative Equilibrium Price
232
Indicative Equilibrium Volume
200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
MDKI
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Emdeki Utama Tbk.

PT Emdeki Utama (the Entity) was established based on Notarial Deed No. 33 of Hobropoerwanto, S.H., dated March 17, 1981.

Read more on MDKI